Arbidol Hydrochloride Market:
WiseGuyReports.com adds “Global Arbidol Hydrochloride Market Research Report 2020 Analysis and Forecast 2026” reports to its database.
Arbidol Hydrochloride is a Russia-made powerful broad-spectrum antiviral which is used for the treatment of number of enveloped and non-enveloped viruses. The drug is majorly used in Russia and China and is effective in treating influenza A & B viruses and hepatitis C virus. Hence the growing number of diseases due to the spread of new type of viruses drives the market for Arbidol. As the virus spreads, the diseases turn into an epidemic and hence the demand for Arbidol Hydrochloride surges. For Instance: In 2020 the spread of the COVID-19 turned into a Pandemic which has created a huge demand for Arbidol for treatment of the disease. As per World of meters, as of 2nd May 2020 the number of Coronavirus Cases have increased to 3.4 million while the death toll from this virus has reached to 239 thousand. The spread of the virus has initiated large number of clinical trials trying to create an effective treatment and vaccine for the disease. These clinical trials involve usage of Arbidol Hydrochloride for treatment. As the national Health Commission of China, in February 2020 issued a guidance selecting Lopinavir-ritonavir and Arbidol for treating COVID-19. The decision for the selection was based on in-vitro cell tests and previous clinical data from SARS and MERS. This further led to an increase in production of Arbidol Hydrochloride in China. As Shijiazhuang Pharmaceutical Group since Mid-January has donated 50,000 boxes of arbidol tablets to the medical staff in Wuhan and since then more orders for the medicine have come in from the clinical medical institutions. The company can produce 900 thousand of Arbidol Hydrochloride capsules per day which is about twice the normal daily volume of production. Also, the Hyderabad-based Indian Institute of Chemical Technology (IICT) has developed a convenient and cost-effective synthetic process for producing antiviral drug Favipiravir. Along with the drug, the institute is working on the production of other drugs namely, Arbidol and Triazavarin for the battling the pandemic. Hence the surge in demand owing to the rising clinical trials has led to the increase in production of arbidol tablets and capsules driving the market towards growth. However, unsuccessful trials impede the growth of the market over the forecast period of 2020-2026.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5387178-global-arbidol-hydrochloride-market-size-study-with-covid
The regional analysis of global Arbidol Hydrochloride market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of urgent care services coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising disposable income, rising incidences of injuries and improving healthcare infrastructure would create lucrative growth prospects for the Arbidol Hydrochloride market across Asia-Pacific region.
Major market player included in this report are:
Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
Yichang Tianren Pharmaceutical Co.,Ltd
Shenyang Coupling Biomedical Technology Co., Ltd.
Shijiazhuang Pharmaceutical Group
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Arbidol Hydrochloride Tablets
Arbidol Hydrochloride Capsules
Arbidol Hydrochloride Granules
Anti Influenza Virus
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026
Target Audience of the Global Arbidol Hydrochloride Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers
For further information on this report, visit – https://www.wiseguyreports.com/reports/5387178-global-arbidol-hydrochloride-market-size-study-with-covid
NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)